Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hans-Peter Buchstaller

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

Journal of medicinal chemistry

Journal of chemical information and modeling

Merck KGaA

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Merck KGaA Jan 1o 1997

Germany

Principal Scientist :: Discovery & Development Technologies

Publications

Andreas Blum, Dieter Dorsch, Nina Linde, Susanne Brandstetter, Hans-Peter Buchstaller, Michael Busch, Nina Glaser, Ulrich Grädler, Aaron Ruff, Carl Petersson, Hanno Schieferstein, Eva Sherbetjian, Christina Esdar
Identification of M4205─A Highly Selective Inhibitor of KIT Mutations for Treatment of Unresectable Metastatic or Recurrent Gastrointestinal Stromal Tumors. Journal of medicinal chemistry (2023)
Andreas Blum, Dieter Dorsch, Nina Linde, Susanne Brandstetter, Hans-Peter Buchstaller, Michael Busch, Nina Glaser, Ulrich Grädler, Aaron Ruff, Carl Petersson, Hanno Schieferstein, Eva Sherbetjian, Christina Esdar
Identification of M4205─A Highly Selective Inhibitor of KIT Mutations for Treatment of Unresectable Metastatic or Recurrent Gastrointestinal Stromal Tumors. Journal of medicinal chemistry 66 (4) (2023)
Andreas Blum, Dieter Dorsch, Nina Linde, Susanne Brandstetter, Hans-Peter Buchstaller, Michael Busch, Nina Glaser, Ulrich Grädler, Aaron Ruff, Carl Petersson, Hanno Schieferstein, Eva Sherbetjian, Christina Esdar
Identification of M4205─A Highly Selective Inhibitor of KIT Mutations for Treatment of Unresectable Metastatic or Recurrent Gastrointestinal Stromal Tumors. Journal of medicinal chemistry 66 (4) (2023)
Hans-Peter Buchstaller, Ada Sala-Hojman, Matthias Leiendecker, Joachim Albers, Uwe Anlauf, Nina Berges, Liming Dong, Thomas Fuchß, Martina Germann, Tim Knehans, Mireille Krier, Marc Lecomte, Daniel Müller, Sandra R Müller, Birgitta Leuthner, Ralph Lindemann, Djordje Musil, Mateusz Nowak, Vivian Reither, Corinna Rettig, Christina E M Schindler, Urszula Pakulska, Dieter Spuck, Ansgar Wegener, Adrian Zarębski
Discovery of Cycloalkyl[ c ]thiophenes as Novel Scaffolds for Hypoxia-Inducible Factor-2α Inhibitors. Journal of medicinal chemistry (2023)
Andreas Blum, Dieter Dorsch, Nina Linde, Susanne Brandstetter, Hans-Peter Buchstaller, Michael Busch, Nina Glaser, Ulrich Grädler, Aaron Ruff, Carl Petersson, Hanno Schieferstein, Eva Sherbetjian, Christina Esdar
Identification of M4205─A Highly Selective Inhibitor of KIT Mutations for Treatment of Unresectable Metastatic or Recurrent Gastrointestinal Stromal Tumors. Journal of medicinal chemistry 66 (4) (2023)
Hans-Peter Buchstaller, Uwe Anlauf, Dieter Dorsch, Sarah Kögler, Daniel Kuhn, Martin Lehmann, Birgitta Leuthner, Sara Lodholz, Djordje Musil, Daniela Radtki, Corinna Rettig, Claudio Ritzert, Felix Rohdich, Richard Schneider, Ansgar Wegener, Stefan Weigt, Kai Wilkinson, Christina Esdar
Optimization of a Screening Hit toward M2912, an Oral Tankyrase Inhibitor with Antitumor Activity in Colorectal Cancer Models. Journal of medicinal chemistry 64 (14) (2021)
Christina E M Schindler, Hannah Baumann, Andreas Blum, Dietrich Böse, Hans-Peter Buchstaller, Lars Burgdorf, Daniel Cappel, Eugene Chekler, Paul Czodrowski, Dieter Dorsch, Merveille K I Eguida, Bruce Follows, Thomas Fuchß, Ulrich Grädler, Jakub Gunera, Theresa Johnson, Catherine Jorand Lebrun, Srinivasa Karra, Markus Klein, Tim Knehans, Lisa Koetzner, Mireille Krier, Matthias Leiendecker, Birgitta Leuthner, Liwei Li, Igor Mochalkin, Djordje Musil, Constantin Neagu, Friedrich Rippmann, Kai Schiemann, Robert Schulz, Thomas Steinbrecher, Eva-Maria Tanzer, Andrea Unzue Lopez, Ariele Viacava Follis, Ansgar Wegener, Daniel Kuhn
Large-Scale Assessment of Binding Free Energy Calculations in Active Drug Discovery Projects. Journal of chemical information and modeling 60 (11) (2020)
Hans-Peter Buchstaller, Uwe Anlauf, Dieter Dorsch, Daniel Kuhn, Martin Lehmann, Birgitta Leuthner, Djordje Musil, Daniela Radtki, Claudio Ritzert, Felix Rohdich, Richard Schneider, Christina Esdar
Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity. Journal of medicinal chemistry 62 (17) (2019)

Hans-Peter Buchstaller.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hans-Peter Buchstaller